KALA logo

Kala Pharmaceuticals (KALA) Company Overview

Profile

Full Name:

KALA BIO, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 20, 2017

Indexes:

Not included

Description:

Kala Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for eye diseases. They use a unique drug delivery technology to improve the effectiveness of medications, aiming to enhance patient outcomes and quality of life for those with vision-related conditions.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 21, 2022

Analyst ratings

Recent major analysts updates

Feb 13, 25 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Aug 19, 24 Oppenheimer
Outperform
May 17, 24 HC Wainwright & Co.
Buy
Apr 2, 24 HC Wainwright & Co.
Buy
Apr 1, 24 Oppenheimer
Outperform
Nov 17, 23 HC Wainwright & Co.
Buy
Aug 11, 23 HC Wainwright & Co.
Buy
May 10, 23 HC Wainwright & Co.
Buy
May 1, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Kala Pharmaceuticals?
  • Does Kala Pharmaceuticals pay dividends?
  • What sector is Kala Pharmaceuticals in?
  • What industry is Kala Pharmaceuticals in?
  • What country is Kala Pharmaceuticals based in?
  • When did Kala Pharmaceuticals go public?
  • Is Kala Pharmaceuticals in the S&P 500?
  • Is Kala Pharmaceuticals in the NASDAQ 100?
  • Is Kala Pharmaceuticals in the Dow Jones?
  • When was Kala Pharmaceuticals's last earnings report?
  • When does Kala Pharmaceuticals report earnings?
  • Should I buy Kala Pharmaceuticals stock now?

What is the ticker symbol for Kala Pharmaceuticals?

The ticker symbol for Kala Pharmaceuticals is NASDAQ:KALA

Does Kala Pharmaceuticals pay dividends?

No, Kala Pharmaceuticals does not pay dividends

What sector is Kala Pharmaceuticals in?

Kala Pharmaceuticals is in the Healthcare sector

What industry is Kala Pharmaceuticals in?

Kala Pharmaceuticals is in the Biotechnology industry

What country is Kala Pharmaceuticals based in?

Kala Pharmaceuticals is headquartered in United States

When did Kala Pharmaceuticals go public?

Kala Pharmaceuticals's initial public offering (IPO) was on July 20, 2017

Is Kala Pharmaceuticals in the S&P 500?

No, Kala Pharmaceuticals is not included in the S&P 500 index

Is Kala Pharmaceuticals in the NASDAQ 100?

No, Kala Pharmaceuticals is not included in the NASDAQ 100 index

Is Kala Pharmaceuticals in the Dow Jones?

No, Kala Pharmaceuticals is not included in the Dow Jones index

When was Kala Pharmaceuticals's last earnings report?

Kala Pharmaceuticals's most recent earnings report was on Nov 12, 2024

When does Kala Pharmaceuticals report earnings?

The next expected earnings date for Kala Pharmaceuticals is Mar 28, 2025

Should I buy Kala Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions